Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mindwalk Holdings Corp (HYFT)

Mindwalk Holdings Corp (HYFT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,389
  • Shares Outstanding, K 46,157
  • Annual Sales, $ 17,590 K
  • Annual Income, $ -21,690 K
  • EBIT $ -9 M
  • EBITDA $ -5 M
  • 60-Month Beta 0.63
  • Price/Sales 3.46
  • Price/Cash Flow N/A
  • Price/Book 5.69

Options Overview Details

View History
  • Implied Volatility 165.22% (-20.03%)
  • Historical Volatility 84.14%
  • IV Percentile 36%
  • IV Rank 12.44%
  • IV High 494.40% on 02/09/26
  • IV Low 118.45% on 12/05/25
  • Expected Move (DTE 25) 0.9775 (76.97%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 2,354
  • Open Int (30-Day) 2,644
  • Expected Range 0.2925 to 2.2475

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 1
  • High Estimate $-0.05
  • Low Estimate $-0.05
  • Prior Year $-0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9900 +28.28%
on 03/30/26
1.4700 -13.61%
on 04/17/26
+0.1100 (+9.48%)
since 03/20/26
3-Month
0.9900 +28.28%
on 03/30/26
2.3900 -46.86%
on 01/23/26
-0.6800 (-34.87%)
since 01/20/26
52-Week
0.4000 +217.50%
on 04/22/25
3.2459 -60.87%
on 08/25/25
+0.8321 (+190.02%)
since 04/17/25

Most Recent Stories

More News
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results

Third Consecutive Quarter of Year-Over-Year Revenue Growth | First Annual Enterprise LensAI™ Platform Contract | Launch of B cell Llama™ Nanobody Discovery Platform

HYFT : 1.2700 (-4.51%)
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era

Peer-reviewed study in ACS Biomacromolecules demonstrates modular VHH potency, cross-variant therapeutic activity, and a newly described immune-priming mechanism; MindWalk holds first right to commercialize...

HYFT : 1.2700 (-4.51%)
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026

The Company to host an earnings conference call via webcast

HYFT : 1.2700 (-4.51%)
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics

MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT ®...

HYFT : 1.2700 (-4.51%)
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease

MindWalk Holdings Corp. (“MindWalk” or the “Company”) (Nasdaq: HYFT) today announced the discovery and validation of monoclonal antibodies and intrabodies that selectively target misfolded, pathogenic...

HYFT : 1.2700 (-4.51%)
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight

Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9

HYFT : 1.2700 (-4.51%)
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight

Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9

HYFT : 1.2700 (-4.51%)
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline

MindWalk (NASDAQ: HYFT), a BioNative AI biotherapeutic research and technology company combining in silico and wet lab operations for biologics discovery and development, today announced...

HYFT : 1.2700 (-4.51%)
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025

The Company to host an earnings conference call via webcast

HYFT : 1.2700 (-4.51%)
MindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025

MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced that Dr. Dirk Van Hyfte, Chief Technology Officer, will participate...

HYFT : 1.2700 (-4.51%)

Business Summary

MindWalk is a Bio-Native AI company transforming drug discovery and development. MindWalk, formerly known as ImmunoPrecise Antibodies Ltd., is based in AUSTIN, Texas.

See More

Key Turning Points

3rd Resistance Point 1.4267
2nd Resistance Point 1.3833
1st Resistance Point 1.3267
Last Price 1.2700
1st Support Level 1.2267
2nd Support Level 1.1833
3rd Support Level 1.1267

See More

52-Week High 3.2459
Fibonacci 61.8% 2.1588
Fibonacci 50% 1.8230
Fibonacci 38.2% 1.4871
Last Price 1.2700
52-Week Low 0.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.